Maxigen Biotech Inc. (TPE:1783)
39.40
+1.30 (3.41%)
Apr 29, 2026, 1:30 PM CST
-5.97% (1Y)
| Market Cap | 3.53B |
| Revenue (ttm) | 811.56M |
| Net Income (ttm) | 265.31M |
| Shares Out | 89.68M |
| EPS (ttm) | 2.94 |
| PE Ratio | 13.40 |
| Forward PE | n/a |
| Dividend | 0.83 (2.18%) |
| Ex-Dividend Date | Sep 5, 2025 |
| Volume | 212,323 |
| Average Volume | 132,945 |
| Open | 38.60 |
| Previous Close | 38.10 |
| Day's Range | 38.60 - 40.00 |
| 52-Week Range | 37.80 - 48.85 |
| Beta | 0.31 |
| RSI | 35.79 |
| Earnings Date | Mar 20, 2026 |